Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.79
Delayed Data
As of 4:01pm ET
 -0.25 / -0.45%
Today’s Change
46.17
Today|||52-Week Range
60.34
-3.94%
Year-to-Date

Today’s Trading

Previous close56.04
Today’s open56.79
Day’s range55.40 - 56.80
Volume995,649
Average volume (3 months)1,431,871
Market cap$109.8B
Dividend yield1.72%
Data as of 4:01pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.65%
Revenue growth (last year)+1.43%
P/E ratio4.1
Price/Sales9.38
Price/Book20.88

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-1.75-4.08%
GSKGlaxoSmithKline-0.45-1.04%
ABBVAbbVie-0.20-0.33%
BMYBristol-Myers Squibb-0.08-0.11%
Data as of 4:01pm ET, 04/29/2016

Financials

Last reporting dateApril 29, 2016
EPS forecast (this quarter)$0.54
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Partner Offers

Search for Jobs